BioCardia, Inc. — Director's Dealing 2020

Apr 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-04-24

Reporting Person: McClung David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-24	Common Stock	A	19312	—	Acquired	21292	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-24	Stock Option (right to buy)	$3.43	A	25540	Acquired	2030-04-24	Common Stock (25540)	Direct

Footnotes

F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020.

F2: The option vests and becomes exercisable as to 1/48th of the shares on May 24, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.